Idoxuridine

碘苷

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameIdoxuridine
Drug Alias Name碘甙idoxuridine碘汞酸钾idoxuridinaidoxuridinum +[19] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsHerpes Simplex
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeD06BB01J05AB02S01AD01
Related LinksWikipediaDrugBankKEGG